{
  "id": 17168845,
  "title": "Aspen raises a $140M IPO in pursuit of a cell therapy for Parkinson’s",
  "url": "https://urgent.news/2026/10/30/aspen-raises-a-140m-ipo-in-pursuit-of-a-cell-therapy-for-parkinsons",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T02:38:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/aspen-neuroscience-parkinsons-ipo-pricing/873050/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The San Diego biotechnology startup is one of several firms working on a cutting-edge technique with the potential to slow or even halt the neurodegenerative condition.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}